BCAL Diagnostics
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4 Cornwallis St, Eveleigh, New South Wal...Phone Number
+61 292094444Website
www.bcaldiagnostics.comRevenue
<$5 MillionStock Symbol
BDXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BCAL Diagnostics
BCAL Diagnostics is an Australian biotechnology company devoted to improving breast cancer outcomes through innovative, non-invasive diagnostic technologies. They have developed BREASTEST, a blood-based test designed to complement traditional mammography, particularly for women with dense breast tissue. Intended for women over 30, their approach aims to enhance early detection and provide clinicians with additional information for accurate assessments. The company emphasizes partnerships with healthcare professionals to empower women and offer greater confidence in their breast health journey.Explore more
BCAL Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BCAL Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BCAL Diagnostics is spiking on competitors!
Check if BCAL Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at BCAL Diagnostics
Earning: See what the market has to say on BCAL Diagnostics recently announced quarterly report
Click to see if BCAL Diagnostics had a recent Job posting/layoffs
Product Launch: Get notified when BCAL Diagnostics launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BCAL Diagnostics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
BCAL Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at BCAL Diagnostics
Find 3 more new buyers
Compare Similar Companies to BCAL Diagnostics
Compare insights from companies similar to BCAL Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BCAL Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BCAL Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BCAL Diagnostics.
BCAL Diagnostics Tech Stack
A closer look at the technologies used by BCAL Diagnostics
BCAL Diagnostics News & Media
BCAL Diagnostics Secures $10 Million Convertible Note Facility - TipRanks.com
The latest announcement is out from BCAL Diagnostics Limited ( ($AU:BDX) ). BCAL Diagnostics Limited has announced the establishment of a $10 million Convertible No...BCAL Findings Presented at 2023 ASCO Annual Meeting
Highlights Presentation at American Society of Clinical Oncology (ASCO) demonstrates potential to detect breast cancer using plasma lipidomic biomarker signature Results reduce the complexity and advance commercial viability of BCAL test BCAL laboratory now operational to advance clinical...BCAL DIAGNOSTICS OPENS NEW LABORATORY IN SYDNEY AS IT ACCELERATES DEVELOPMENT OF ITS BREAST CANCER BLOOD SCREENING TOOL
Marks Important Milestone in Commercialization of Blood Screening Tool that is Intended to be used Alongside Current Breast Cancer Screening Methods SYDNEY, May 4, 2023 /PRNewswire/ -- BCAL Diagnostics Limited (ASX:BDX) (BCAL or Company) an Australian-based biotechnology company announced...BCAL Files Foundational Patent Application
SYDNEY, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- Breast cancer screening and diagnostic company BCAL Diagnostics Limited (ASX:BDX, ‘BCAL’ or the ‘Company’) is pleased to announce the filing of a provisional patent application number 2022901245 at IP Australia covering key lipid biomarkers that form part of its revolutionary blood-based breast cancer diagnostic.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BCAL Diagnostics
Sign Up For FreeTo access detailed company insights
BCAL Diagnostics is an Australian biotechnology company devoted to improving breast cancer outcomes through innovative, non-invasive diagnostic technologies. They have developed BREASTEST, a blood-based test designed to complement traditional mammography, particularly for women with dense breast tissue. Intended for women over 30, their approach ai... Read More
